A web-blog (formerly known as Stu's Views and MS News), now published by MS Views and News, a patient advocacy organization. The information on this blog helps to Empower those affected by Multiple Sclerosis globally, with education, information, news and community resources.
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Tuesday, October 21, 2014
RRMS and CIS—Baseline Characteristics
Clinical trials can sometimes be hard to compare because the patients enrolled in those trials start out with different characteristics. This data visualization clearly reveals those differences. We analyzed 74 MS clinical trials reported between 1993 and 2014, and we extracted mean values of the 5 most frequently reported characteristics: age, gender, Expanded Disability Status Scale (EDSS) score, number of gadolinium enhancing lesions (GdEnh), and volume of T2 lesions (VolT2) in cm3. We then displayed those characteristics on radar plots.
The two large radar plots at the top represent the overall means for relapsing remitting MS (RRMS) and clinically isolated syndrome (CIS). On each axis you may mouse over the dot to display the corresponding value.